Press "Enter" to skip to content

New patent for Takeda Pharms drug ICLUSIG

0
Copyright © DrugPatentWatch. Originally published at New patent for Takeda Pharms drug ICLUSIG

Annual Drug Patent Expirations for ICLUSIG
Annual Drug Patent Expirations for ICLUSIG

Iclusig is a drug marketed by Takeda Pharms Usa and is included in one NDA. It is available from one supplier. There are three patents protecting this drug.

Drug patent litigation for ICLUSIG.

This drug has eigthy patent family members in twenty-three countries.

The generic ingredient in ICLUSIG is ponatinib hydrochloride. One supplier is listed for this compound. Additional details are available on the ponatinib hydrochloride profile page.

For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com

Make Better Decisions with DrugPatentWatch

» Start Your Free Trial Today «

Copyright © DrugPatentWatch. Originally published at New patent for Takeda Pharms drug ICLUSIG
    DrugPatentWatch - Make Better Decisions